The success of acinetobacter species; genetic, metabolic and virulence attributes.
about
Acinetobacter baumannii: evolution of a global pathogenThe genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequencesHIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammationClonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospitalVaccines for Acinetobacter baumannii: thinking "out of the box".Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter InfectionsIdentification of unique cardiolipin and monolysocardiolipin species in Acinetobacter baumannii.A New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of Multidrug-Resistant Acinetobacter baumannii.Microbial profiling of combat wound infection through detection microarray and next-generation sequencing.Acinetobacter baumannii utilizes a type VI secretion system for bacterial competitionThe clinical characteristics, carbapenem resistance, and outcome of Acinetobacter bacteremia according to genospecies.Real-time fluorescence loop mediated isothermal amplification for the detection of Acinetobacter baumannii.Insertions or deletions (Indels) in the rrn 16S-23S rRNA gene internal transcribed spacer region (ITS) compromise the typing and identification of strains within the Acinetobacter calcoaceticus-baumannii (Acb) complex and closely related members.Mini-review: Microbial coaggregation: ubiquity and implications for biofilm development.Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D.Molecular Analysis of Bacterial Microbiota on Brazilian Currency Note Surfaces.Microbial translocation and microbiome dysbiosis in HIV-associated immune activationInhibition of AAC(6')-Ib-mediated resistance to amikacin in Acinetobacter baumannii by an antisense peptide-conjugated 2',4'-bridged nucleic acid-NC-DNA hybrid oligomer.Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis.Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets.Joint Transcriptional Control of Virulence and Resistance to Antibiotic and Environmental Stress in Acinetobacter baumannii.Outer membrane Protein A plays a role in pathogenesis of Acinetobacter nosocomialis.Use of Comparative Genomics To Characterize the Diversity of Acinetobacter baumannii Surveillance Isolates in a Health Care Institution.Transcriptomic analysis of the highly efficient oil-degrading bacterium Acinetobacter venetianus RAG-1 reveals genes important in dodecane uptake and utilization.Acinetobacter baumannii Isolated from Lebanese Patients: Phenotypes and Genotypes of Resistance, Clonality, and Determinants of Pathogenicity.Outbreak of extensively drug-resistant Acinetobacter baumannii indigo-pigmented strains.New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis.Transcriptome Remodeling of Acinetobacter baumannii during Infection and Treatment.Constraint-based modeling identifies new putative targets to fight colistin-resistant A. baumannii infections.Comparative genomic analysis of Acinetobacter strains isolated from murine colonic crypts.Phylogenetic signal in phenotypic traits related to carbon source assimilation and chemical sensitivity in Acinetobacter species.Characterization of blaOXA-143 variants in Acinetobacter baumannii and Acinetobacter pittii.Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.Draft genome sequence of Acinetobacter pittii ST643 shared by cystic fibrosis patients.Simultaneous Identification of Multiple β-Lactamases in Acinetobacter baumannii in Relation to Carbapenem and Ceftazidime Resistance, Using Liquid Chromatography-Tandem Mass Spectrometry.Discovery and Characterization of New Hydroxamate Siderophores, Baumannoferrin A and B, produced by Acinetobacter baumannii.Small, Enigmatic Plasmids of the Nosocomial Pathogen, Acinetobacter baumannii: Good, Bad, Who Knows?Acinetobacter baumanni - understanding and fighting a new emerging pathogen.Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii.The Environmental Acinetobacter baumannii Isolate DSM30011 Reveals Clues into the Preantibiotic Era Genome Diversity, Virulence Potential, and Niche Range of a Predominant Nosocomial Pathogen
P2860
Q27008568-12EA2CD1-AA21-4ABE-9B0E-0CCD5CD9E4C7Q28652539-41E0B855-5842-47D1-86CD-38EF35DCBCADQ30839904-BF6755B6-46BC-42CC-8553-D82628A396A4Q33610935-68152F10-CB6E-401D-BA32-CBDECBD491BAQ33637895-C71EBF08-6DC9-485F-A4D9-9E6FE4436A55Q33732524-92BFF9D8-813A-4DE1-A6E1-EF4ACCAEDB1BQ33774463-F67079AE-EE59-41A0-AFC0-0DE42925A634Q33792789-935BDDFC-B67B-42CF-BFD3-88845982EA50Q33900191-895D6B65-0937-4AB7-B128-25177D772AE2Q34635109-8B4CF05E-1FE9-4908-93D9-D412E9768B65Q34766027-55FD1575-D74F-44DF-A0B7-DC925FC1E4ACQ34812152-B0631E82-EB6A-4EC8-9C07-1B8FD257868AQ35228634-3A752564-50ED-4D23-B5C2-455278EE7A3BQ35447292-4EB3BA63-EB77-464E-AD28-05B2A65012DFQ35778670-60239E7C-160C-4E7F-9344-E131581D7A70Q35823099-8C4F9E45-12A6-40A3-A304-1082135759D1Q35872112-7A9886C5-6AEC-4C52-9464-211CA2232326Q35960810-BB69F6CF-AA49-4E63-AF00-443F01CAA120Q36099594-B12D0400-9F4C-406F-B242-D3D6038FED1AQ36135237-285C3B7E-B7E0-4086-AC92-34E5237DB985Q36318967-8026A1EB-3FB2-440C-8D65-758286791130Q36913254-928FE950-3559-4F1F-B6F5-E84CFF1BB23DQ37287931-AE8CAC87-8E53-4751-8A95-C789D8334444Q37357800-BBED76E2-423E-49D7-BFF6-64EF96AF010AQ37438110-A63C67AB-F7DC-4509-9F34-4BD938C2F1DFQ37470407-BAA0F431-57CE-416D-AEF1-FAFD31452930Q37519869-63CA2634-0446-44AE-A042-900FCFE44B68Q37685595-7512A658-68B0-49B6-AB84-302782441832Q38670032-16015032-9B2A-4C16-9EA7-4F47D7E0E06DQ38683796-4E246D26-E558-46F0-B0D4-A256C6E6FA03Q38812200-51AAF42F-94B7-45A1-BEF8-ED086B2031E5Q38848691-873D4653-6500-430A-AF63-BA7440569BD2Q39003164-7678DBA6-788F-4604-8954-D4E777FAB584Q40532485-79DED456-4294-48C2-A0E0-8CC67F8D555BQ40673302-D2399E45-590B-4C18-97A7-438D4420274DQ41075973-121D2E25-1E72-4E1D-8443-051845A45ED0Q41436302-E2EFE976-4B65-4B5E-A9AE-910F869E92D5Q41461806-60BDA532-3525-4D31-8E84-9B102EEC23D0Q41561999-EFB05A60-47C0-4331-848E-88F44CB8BF8FQ41692213-F2D70F88-DA66-4120-A48D-D59431D725A6
P2860
The success of acinetobacter species; genetic, metabolic and virulence attributes.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The success of acinetobacter species; genetic, metabolic and virulence attributes.
@ast
The success of acinetobacter species; genetic, metabolic and virulence attributes.
@en
type
label
The success of acinetobacter species; genetic, metabolic and virulence attributes.
@ast
The success of acinetobacter species; genetic, metabolic and virulence attributes.
@en
prefLabel
The success of acinetobacter species; genetic, metabolic and virulence attributes.
@ast
The success of acinetobacter species; genetic, metabolic and virulence attributes.
@en
P2093
P2860
P50
P1433
P1476
The success of acinetobacter species; genetic, metabolic and virulence attributes.
@en
P2093
Anna de Breij
Doyle V Ward
Harald Seifert
Mark D Adams
Peter H Nibbering
P2860
P304
P356
10.1371/JOURNAL.PONE.0046984
P407
P50
P577
2012-10-29T00:00:00Z